We’re headed to the @Jefferies Global Healthcare Conference in London next week. You can listen to our presentation on Wed, Nov 19 at 11:30am GMT/6:30am ET here: https://t.co/fnXLcnIjdP #JefferiesHealthcare

Today we shared landmark results from our Ph 3 PEAK trial in #GIST. We are deeply grateful 2 the patients, families & researchers whose participation helped make this possible. Read the release: https://t.co/oqVlBy1OZI . Join our webcast at 8am ET: https://t.co/ZfgP1yA1bo

Today we reported our 3Q25 financial results. Read the PR here: https://t.co/Eleu2e8NN6. We also announced 2 oral presentations & a poster with bezuclastinib at #ASH25 & a poster with our newest program, a JAK2 V617F mutant-selective inhibitor. Read more: https://t.co/UdtOhlBj4E.

The FDA has granted BTD for bezuclastinib in #NonAdvSM patients previously treated with avapritinib as well as in patients with SSM; populations with no currently approved standard of care. We'll also report PEAK TLR in Nov & APEX TLR in Dec. Read the PR: https://t.co/3qbSU6Be6v

We’re proud to be one of this year’s sponsors of the European Competence Network on Mastocytosis (ECNM) annual meeting. The team is here and looking forward to connecting with systemic #mastocytosis disease experts. #NonAdvSM #AdvSM

Our Medical Affairs team is at the 2025 Society of Hematologic Oncology Annual Meeting (SOHO 2025) in Houston. Stop by booth #118 to learn more. See you there! #NonAdvSM #AdvSM

Tune in next week on Wed, Sept 3 at 9:00am ET to listen to our fireside chat at Citi’s 2025 Biopharma Back-to-School Conference. Register and join here https://t.co/qPO8ieWrm2.

Today we reported our financial results for 2Q 2025. It’s been an exciting year at Cogent and there’s still lots to look forward to as we prepare for two pivotal trial readouts in GIST and AdvSM in the second half. Check out the release here: https://t.co/cbA1GxyfE3

Every July 13, we recognize #GISTAwarenessDay—a day dedicated 2 raising awareness & supporting those affected by Gastrointestinal Stromal Tumors. At Cogent, we’re proud to partner with the @Liferaftgroup & others in the GIST community 2 support those impacted by this rare cancer.

Today we reported positive top-line results from Part 2 of our SUMMIT trial in #NonAdvSM achieving statistical significance across all primary & key 2ndary endpoints. Read the release: https://t.co/8g08XTxw0Q Our webcast will begin at 8am ET. Join: https://t.co/Jvcd6WabOm

We were thrilled to attend #EHA2025 and #EAACI2025!

Please note our new presentation time: 8:10am ET, Thursday, June 5 at the Jefferies Global Healthcare Conference. Register and listen in here: https://t.co/F65ZtB42u6

Join us on Thursday at 7:35am ET for our presentation at the Jefferies Global Healthcare Conference. Register and listen in here: https://t.co/F65ZtB42u6

Are you in Chicago for #ASCO25? Come find us in the Exhibit Hall at Booth 27165 to learn about our commitment to discover and develop potential best-in-class therapies for patients with genetically defined diseases. #NonAdvSM #GIST #AdvSM

Today we reported our first quarter 2025 financials. We’re looking forward to a data-rich year ahead with top-line results on track from our SUMMIT, APEX and PEAK trials. Read the full release here: https://t.co/t1pwTasZw3

We were thrilled to present 4 preclinical posters at #AACR25. Thanks 2 all who came to chat as we shared updated results from our pipeline of potential best-in-class targeted therapies. Read our press release: https://t.co/6Cl9PjpbkE & see our posters: https://t.co/5CBIhY91EN

Proud to sponsor the @sarcomapatients 2025 #SPAGN Annual Conference & support this important gathering of global patient advocates, researchers, & healthcare professionals coming together to improve outcomes for those living with sarcoma and #GIST #SarcomaAwareness #GISTAwareness

We’re excited 2 sponsor the @curecc #CCFAnnualConference & grateful 2 be able 2 share our progress on our FGFR Clinical Program as we learn from leading experts, researchers & the #Cholangiocarcinoma Patient Community. Stop by the Cogent table 2 learn more. #ccfac25 #CCAhope

We recognized #CholangiocarcinomaAwarenessMonth by going green in sweatshirts from @curecc. We're committed 2 supporting those affected by #cholangiocarcinoma & working w/groups like CCF to create change for this community by advancing science thru our FGFR program. #GreenforCCA

Today we released our fourth quarter and full year financial results and recent business highlights and reiterated our anticipated milestones. Our progress in 2024 underscores the positive momentum we're carrying into 2025. Learn more here: https://t.co/7v270gFHfr